Delivery Order SPE2DB22D2211-SPE2DB25FSBPX
- Not listed
- The Defense Logistics Agency awarded a $11,561.05 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Hydrocort-Pramoxine 2.5-1% cream in 30-gram containers. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,741.30 to AmerisourceBergen Drug Corp for Hydrocort-Pramoxine 1%-1% cream in 30-gram units. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of July 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide a pharmaceutical product - Hydrocort-Pramoxine 2.5-1% Cream 30GM. The $2,002.93 contract has an ultimate completion date of April 12, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp to deliver a comprehensive range of...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Hydrocort-Pramoxine 1%-1% Cream, 30 grams, with a ceiling value of $1,724.46 and a completion date of April 15, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by...
- This federal contract award is a firm fixed price delivery order to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, for the supply of a hydrocortisone-pramoxine topical cream. The contract is valued at $4,321.97 and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The delivery order has a period of performance through March 19, 2024. Amerisourcebergen Drug Corporation holds an Indefinite Delivery Contract (IDC) with DLA valued at up to...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,622.91 to AmerisourceBergen Drug Corp for the supply of 4567330281 - Hydrocortisone 1% Cream 28.4GM. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, which runs...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of a pharmaceutical product, Hydrocort-Pramoxine 1%-1% Cream in 30 gram units, with a completion date of January 26, 2024 and a potential value of $3,011.64. This delivery order is issued under a larger indefinite delivery contract (IDC) held by...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hydrocortisone-Pramoxine 2.5-1% Cream, a topical medication, and has a ceiling value of $1,515.64. The contract has an ultimate completion date of August 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,950.78, is for the delivery of 4563117240 HYDROCORT-PRAMOXINE 2.5-1% CRM 28.4GM, a medical supply. The contract has a firm fixed price pricing type and an ultimate completion date of December 18, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, to Amerisourcebergen Drug Corp's Corporate Office division. The $2,052.67 firm-fixed-price contract is for the delivery of 4565541593 - Hydrocortisone Cream, a pharmaceutical product. The award has an ultimate completion date of August 27, 2024. Amerisourcebergen is a large pharmaceutical distributor that has been awarded numerous indefinite delivery contracts (IDCs) with the DLA...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSBPXDelivery Order
The Defense Logistics Agency awarded a $3,622.98 delivery order to AmerisourceBergen Drug Corp for Hydrocort-Pramoxine 2.5-1% cream in 30-gram units, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger contract vehicle with the Defense Logistics Agency. This delivery order falls under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The parent IDC enables the company to fulfill federal medical procurement needs across multiple therapeutic domains, serving entities including the Defense Health Agency and U.S. Coast Guard through flexible contract mechanisms designed to support global pharmaceutical supply requirements for the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 7/25/25 |